PRESS RELEASE published on 10/23/2025 at 22:35, 1 year ago IEH Corporation to Present at the GeoInvesting Atrium Index Virtual Investor Conference on Tuesday, October 28, 2025 IEH Corporation to present at Atrium Index Virtual Investor Conference on October 28, 2025. Event hosted by MS Microcaps and GeoInvesting for investors in quality smaller cap companies Virtual Investor Conference IEH Corporation Atrium Index MS Microcaps GeoInvesting
PRESS RELEASE published on 10/23/2025 at 22:30, 1 year ago PJX Resources Announces Warrant Extension and Exploration Update PJX Resources Inc. plans to extend the expiration date of share purchase warrants by 12 months. Exploration update on mineralization discovery Mineral Exploration PJX Resources Inc. Sullivan Deposit Share Purchase Warrants TSXV Exchange
PRESS RELEASE published on 10/23/2025 at 22:30, 1 year ago Bird River Announces Final Tranche of Private Placement and Shares for Debt Transaction Bird River Resources Inc. announces non-brokered private placement of up to 25,000,000 Common Shares at $0.10/share for gross proceeds of $2,500,000. Proceeds to be used for general corporate purposes. Statutory hold period of 4 months. Company focuses on mineral exploration and holds a net royalty smelter interest in platinum palladium property in Manitoba Private Placement Common Shares Mineral Exploration Manitoba Bird River Resources Inc.
PRESS RELEASE published on 10/23/2025 at 22:29, 1 year ago EQS-Adhoc: Cherry SE: Argand Partners, LP, on Behalf of Certain of its Affiliates, Commits to Provide Liquidity in an Amount of EUR 5.7 million Cherry SE secures EUR 5.7 million liquidity commitment from Argand Partners, LP to purchase shares and inventory, strengthening financial position Cherry SE Share Purchase Argand Partners Liquidity Commitment Inventory Arrangement
PRESS RELEASE published on 10/23/2025 at 22:12, 1 year ago Pentixapharm Strengthens Pipeline Prioritization and Improves Cost Structure Pentixapharm strengthens pipeline prioritization, reduces early-stage research activities, and cuts costs by 50%. Focus on Phase 3-ready program for treatment-resistant hypertension diagnosis Clinical Development Cost Reduction Pentixapharm Pipeline Prioritization Diagnosis Program
PRESS RELEASE published on 10/23/2025 at 21:37, 1 year ago Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program Turkiye Garanti Bankasi A.S. redeems debt instrument issued under MTN program abroad. Amount redeemed: USD 13,750,000 Turkiye Garanti Bankasi A.S. Redemption MTN Program Debt Instrument USD 13,750,000
PRESS RELEASE published on 10/23/2025 at 21:15, 1 year ago Résultats annuels 2025 Performances solides dans un contexte de prix d'électricité toujours volatils Fortes perspectives de croissance pour 2026/2027 Objectifs 2030 confirmés La Française de l'Énergie publie ses résultats annuels 2025 avec maintien de la rentabilité malgré les défis du marché de l'électricité, confirmant ses objectifs pour 2030 Croissance Résultats Annuels La Française De L'Énergie Énergie Bas Carbone Objectifs 2030
PRESS RELEASE published on 10/23/2025 at 21:15, 1 year ago FY2025 annual results Solid performance amid continued volatility in electricity prices Strong growth prospects for 2026 and 2027 2030 objectives confirmed FDE (Euronext: FDE - ISIN: FR0013030152) reports solid FY2025 results with revenue of €30.4m, EBITDA margin at 57%, and net income of €3.7m. Strong growth prospects for 2026 and 2027, with focus on low-carbon energy production Revenue Growth Prospects Low-carbon Energy FDE FY2025
PRESS RELEASE published on 10/23/2025 at 20:59, 1 year ago EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm Focuses Development on Advanced Clinical Programs and Strengthens Financial Position by Discontinuing Preclinical Activities Pentixapharm Holding AG strengthens financial position by focusing on advanced clinical programs and discontinuing preclinical activities, reducing costs and extending cash runway Financial Position Cost Reduction Clinical Programs Pentixapharm Preclinical Activities
PRESS RELEASE published on 10/23/2025 at 20:42, 1 year ago Moderna Named a Top Employer by Science for Eleventh Consecutive Year Moderna, Inc. named a top employer in biopharmaceutical industry by Science for 2025. Recognized for innovation, commitment, and culture Moderna Inc. Biopharmaceutical Industry MRNA Technology Top Employer Science Survey
Published on 11/04/2026 at 23:10, 2 hours 17 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 2 hours 27 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 3 hours 12 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 3 hours 22 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 00:02, 1 hour 24 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 5 hours 45 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 6 hours 2 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 6 hours 44 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 7 hours 22 minutes ago Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 18:00, 7 hours 26 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 7 hours 26 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 7 hours 43 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026